DocGo (NASDAQ:DCGO) PT Lowered to $5.00

DocGo (NASDAQ:DCGO) had its price objective dropped by stock analysts at Cantor Fitzgerald from $11.00 to $5.00 in a report released on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 58.23% from the stock’s current price.

A number of other equities research analysts have also issued reports on DCGO. Stifel Nicolaus lowered their target price on DocGo from $8.00 to $6.50 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Canaccord Genuity Group dropped their price objective on DocGo from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday, April 11th. BTIG Research decreased their price target on shares of DocGo from $13.00 to $11.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Finally, Needham & Company LLC cut their price target on shares of DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 29th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $9.58.

DocGo Stock Performance

Shares of DCGO stock traded down $0.34 during trading hours on Thursday, reaching $3.16. The company had a trading volume of 1,011,977 shares, compared to its average volume of 1,441,360. DocGo has a twelve month low of $2.78 and a twelve month high of $10.82. The company has a market capitalization of $329.18 million, a P/E ratio of 44.86, a price-to-earnings-growth ratio of 0.41 and a beta of 0.96. The stock’s fifty day simple moving average is $3.70 and its 200 day simple moving average is $4.42.

DocGo (NASDAQ:DCGO) last posted its earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.07). DocGo had a net margin of 1.10% and a return on equity of 2.01%. The company had revenue of $199.25 million during the quarter, compared to analyst estimates of $195.48 million. As a group, equities analysts expect that DocGo will post 0.31 earnings per share for the current year.

Insider Transactions at DocGo

In other news, Director Michael J. Burdiek bought 10,000 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was bought at an average price of $3.61 per share, for a total transaction of $36,100.00. Following the transaction, the director now owns 571,595 shares in the company, valued at $2,063,457.95. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 13.78% of the company’s stock.

Institutional Trading of DocGo

Several hedge funds have recently added to or reduced their stakes in DCGO. Arizona State Retirement System raised its stake in shares of DocGo by 8.3% in the 3rd quarter. Arizona State Retirement System now owns 26,516 shares of the company’s stock worth $141,000 after buying an additional 2,042 shares in the last quarter. Worth Venture Partners LLC lifted its stake in DocGo by 36.3% in the 3rd quarter. Worth Venture Partners LLC now owns 16,028 shares of the company’s stock worth $85,000 after acquiring an additional 4,265 shares in the last quarter. AJOVista LLC purchased a new stake in DocGo in the 4th quarter worth about $25,000. Principal Financial Group Inc. increased its position in DocGo by 25.2% in the 3rd quarter. Principal Financial Group Inc. now owns 25,591 shares of the company’s stock worth $136,000 after purchasing an additional 5,154 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in DocGo by 42.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,020 shares of the company’s stock worth $128,000 after purchasing an additional 7,166 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.